Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Kodaira
Clinical trial register · Japan

Clinical Trials in Kodaira, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Fukuoka 557 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354

Trials with a site in Kodaira

27 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Novartis Pharmaceuticals
Observational
80
Toyoake, Fukuoka, Kyoto, Kodaira
2026-10-07
Recruiting
Janssen Research & Development, LLC
Phase 3
348
Akita, Karatsu, Kawasaki, Kobe, Kodaira, Koshigaya, Maebashi, Minatoku
2026-07-23
Recruiting
UCB BIOSCIENCES, Inc.
Phase 3
200
Chiyoda-ku, Kodaira, Kurume, Musashimurayama-shi, Osaka, Setagaya-ku
2026-07-14
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
NCT07498426Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals
Phase 3
300
Nagoya, Gifu, Bunkyo Ku, Kodaira, Yonago
2026-06-03
Recruiting
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
NCT07486934Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy, Steinert Disease
Dyne Therapeutics
Phase 3
150
Kashiwazaki, Suita-shi, Toyonaka-Shi, Kodaira, Ube-Shi
2026-05-14
Recruiting
Eli Lilly and Company
Phase 2
450
Chikugo, Fukushima, Hachinohe, Hiratsuka, Karatsu, Kodaira, Kumamoto, Kurume
2026-02-10
Recruiting
Sanofi
Phase 3
160
Kōriyama, Sapporo, Yahaba, Higashi-Matsuyama, Kodaira, Kyoto, Tokyo
2026-01-14
Recruiting
National Center of Neurology and Psychiatry, Japan
Not applicable
25
Kodaira
2025-11-01
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Ōbu, Fujioka, Kodaira, Shinjuku Ku, tabashi City
2025-08-07
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
156
Izumi, Kodaira
2025-06-10
Recruiting
National Center of Neurology and Psychiatry, Japan
Phase 2
30
Kodaira
2025-04-09
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
300
Higashi-Matsuyama, Bunkyo-Ku, Kodaira
2025-04-01
Active, closed
argenx
Phase 3
154
Bunkyō City, Chūōku, Kodaira, Nagoya, tabashi City, Ube
2024-12-18
Active, closed
NS-050/NCNP-03 in Boys With DMD (Meteor50)
NCT06053814Duchenne Muscular Dystrophy
NS Pharma, Inc.
Phase 1/2
20
Nagara, Nishinomiya, Sendai, Toyonaka, Kodaira
2024-09-18
Recruiting
Sanofi
Phase 3
160
Yokohama, Higashi-Matsuyama, Kawagoe, Yaizu, Kodaira, Ōta-ku, Amagasaki, Chiba
2024-08-21
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
109
Sayama, Kawagoe, Yaizu, Bunkyo-Ku, Kodaira, Chiba, Fukuoka, Saga
2024-07-12
Active, closed
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
NCT05996003Duchenne Muscular Dystrophy, Exon 44, DMD
NS Pharma, Inc.
Phase 2
20
Fukui-shi, Nagara, Toyonaka, Moriyama-shi, Kodaira
2024-02-22
Active, closed
argenx
Observational
152
Kodaira, Yurihonjō
2024-02-13
Active, closed
Sanofi
Phase 3
943
Kōriyama, Asahikawa, Himeji, Sagamihara, Higashi-Matsuyama, Kodaira, Chiba, Fukuoka
2023-12-27
Active, closed
Sanofi
Phase 3
1,655
Kōriyama, Asahikawa, Sapporo, Yahaba, Sagamihara, Higashi-Matsuyama, Kodaira, Tachikawa
2023-12-13
By invitation
Sarepta Therapeutics, Inc.
Phase 3
400
Kobe, Kodaira, Tokyo
2023-09-27
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
148
Toyonaka-shi, Kodaira, Shinjuku-ku
2023-05-31
By invitation
UCB Biopharma SRL
Phase 3
300
Fukuoka, Hachioji-shi, Hiroshima, Hōfu, Itami, Kodaira, Koshi-shi, Kyoto
2022-02-03
Active, closed
UCB Biopharma SRL
Phase 3
113
Chiba, Isehara, Kitakyushu-shi, Kodaira, Koriyama-shi, Sendai, Shinjuku-ku, Suita-shi
2022-02-02
Recruiting
UCB Biopharma SRL
Phase 3
350
Fukuoka, Hachioji-shi, Hamamatsu, Hiroshima, Hōfu, Itami, Kodaira, Koshi-shi
2021-12-07
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Tōon, Sapporo, Shiwa-Gun, Sendai, Kawagoe, Kodaira, Shinjuku-ku, Chiba
2018-12-28
Recruiting
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Observational
120
Suita, Kodaira
2014-01
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-japan/city/kodaira

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies with a site in Kodaira.

How many clinical trials are recruiting in Kodaira?

12 of the 27 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 12 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kodaira), 27 studies
PhaseStudiesRecruitingShare
Phase 318766.7%
Phase 24214.8%
Observational3211.1%
Not applicable113.7%
Phase 1/2103.7%

Most active sponsors

Lead sponsors with the most studies (Kodaira)
Lead sponsorStudiesRecruiting
Sanofi62
Novartis Pharmaceuticals42
UCB Biopharma SRL31
argenx20
National Center of Neurology and Psychiatry, Japan22
NS Pharma, Inc.20
Sarepta Therapeutics, Inc.20
Dyne Therapeutics11
Eli Lilly and Company11
Ionis Pharmaceuticals, Inc.10
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.